Efficacy and safety of turmeric 1% emollient cream in the control of chronic kidney disease-associated pruritus in Hemodialysis patients: A randomized double-blind clinical trial

Introduction@#Chronic kidney disease-associated pruritus (CKD-aP) remains a frequent and distressing symptom in hemodialysis patients, fur- ther compromising their quality of life. Turmeric, or Curcuma longa, is a naturally-occurring, widely available product that inhibits major inflamma- tory mechanisms associated with CKD-aP.@*Objectives@#This study aimed to determine the efficacy and safety of turmeric 1% emollient cream versus a bland emollient in the reduction of chronic kidney disease-associated pruritus in hemodialysis patients.@*Methods@#This study was a randomized, double-blind, controlled trial of the effect of turmeric 1% cream in the reduction of chronic kidney disease associated pruritus in hemodialysis patients compared to a bland emollient. The main outcome measure was the proportion of subjects who demonstrated response to treatment, as well as the incidence of adverse effects.@*Results@#Intention to treat analysis on 106 patients, 53 assigned to turmeric 1% cream and 53 to bland emollient cream, was done. There was a sig- nificant difference (P=0.03) in the proportion of patients who achieved treatment success between the turmeric group (66%) and bland emollient group (45%). The mean decrease in pruritus score (VAS) of the group treated with turmeric was significantly greater than that of the bland emol- lient group (P=0.018). No adverse effects were noted in both groups.@*Conclusion@#Among hemodialysis patients diagnosed with CKD-aP, topical application of turmeric 1% cream twice daily for four weeks was supe- rior to that of bland emollient cream based on efficacy and safety outcome measures.

Sociodemographic and Clinical Profile of Geriatric Patients seen at the Southern Philippines Medical Center Department of Dermatology from January 2016 to December 2019

Introduction@#Geriatric health has become a major issue worldwide. According to the World Health Organization(WHO), between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. There is paucity of literature involving the spectrum of frequencies of Filipino geriatric dermatoses.@*Objectives@#To report on sociodemographic and clinical profiles of geriatric patients seen at the department of Dermatology of Southern Philip- pines Medical Center from January 2016 to December 2019.@*Methods@#A retrospective descriptive study was conducted. Sociodemographic and clinical parameters were recorded and analyzed. Descriptive statistics such as frequencies and percentages were used.@*Results@#Study population involved 470 patients with 372 out-patients and 98 in-patients. There was a preponderance of elderly patients with ages of 70-79 and a slight female predominance. Most were married, residents of Davao City, retired or unemployed and had no vices. About 711 derma- tologic dermatoses were recorded. Majority of concerns(22.08%) were classified under allergic and eczematous disorders. A greater number of cases were managed by a combination of topical and oral medications. A proportion of these patients(38.09%) had at least one known co-morbid condition; most common of which is hypertension. The top 10 most common dermatoses include (1)xerosis, (2)contact dermatitis, (3)lichen simplex chronicus, (4)dermatophytosis, (5)stasis derma- titis, (6)seborrheic dermatitis and seborrheic keratosis, (7)acrochordon, (8)psoriasis vulgaris, (9)herpes zoster and (10)verruca plana.@*Conclusion@#Geriatric dermatology is an emerging branch in the new millennium. Raising the level of awareness about these dermatoses may be crucial in proper management and improved quality of life for Filipino elderly patients.